The Effectiveness of the Low-Level Laser, Antibiotic and Surgical Therapy in the Treatment of Medication-Related Osteonecrosis of the Jaws: A Case Report
Journal of Lasers in Medical Sciences,
Vol. 11 No. 1 (2020),
18 January 2020
,
Page 98-103
Abstract
Introduction: Bisphosphonates consist of a range of drugs used in the treatment of osteopathy or some osteotropic malignancies. Medication-related osteonecrosis of the jaws (MRONJ) is a serious adverse consequence from their use. Conventional treatment is not always effective, so it is necessary to resort to the use of adjuvant therapies. This study aimed to evaluate the effectiveness of the association of surgery, antibiotic therapy and low-level laser (LLL) therapy as a treatment strategy for MRONJ through the presentation of a clinical case.
Case presentation: A 49-year-old patient, female gender, presented for diagnosis and treatment of bone lesions in the maxillae. The patient reported that she had used zoledronate for one year. Five years later there were two painless bone lesions in both sides of maxilla, following extraction of the first upper molars. Clinical, tomographic and histopathologic examination established the diagnosis of MRONJ. The treatment consisted of curettage of necrotic bone, antibiotics and thirteen LLL therapy sessions. The integral mucosal healing was observed after two months of follow-up and no symptoms were detected. The patient was evaluated at six and 12 postoperative months without complications.
Conclusion: The combination of surgery, antibiotic therapy and LLL therapy has shown be effective in the treatment of MRONJ.
- Anti-bacterial agents
- Diphosphonates
- Laser therapy
- Oral surgical procedures
- Osteonecrosis.
How to Cite
References
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American Association of Oral and Maxillofacial Surgeons position Paper on Medication-Related Osteonecrosis of the Jaws - 2014 Update. J Oral Maxillofac Surg. 2014;72(10): 1938-56. doi: 10.1016/j.joms.2014.04.031.
Drake MT, Clarke BL, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc. 2008;83(9):1032-45. doi: 10.4065/83.9.1032.
Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61(9):1115-7. doi: 10.1016/s0278-2391(03)00720-1.
Gómez Font R, Martínez García ML, Olmos Martínez JM. Osteochemonecrosis of the jaws due to bisphosphonate treatments. Update. Med Oral Patol Oral Cir Bucal. 2008;13(5):e-318-24.
Pansani TN, Basso FG, Turirioni AP, Kurachi C, Hebling J, de Souza Costa CA. Effects of low-level laser therapy on the proliferation and apoptosis of gingival fibroblasts treated with zoledronic acid. Int J Oral Maxillofac Surg. 2014;43(8):1030-4. doi: 10.1016/j.ijom.2014.02.011.
Reid IR, Bolland MJ, Grey AB. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone. 2007;41(3):318-20. doi: 10.1016/j.bone.2007.04.196.
Saito T, Izumi K, Shiomi A, Uenoyama A, Ohnuki H, Kato H, et al. Zoledronic acid impairs re-epithelialization through down-regulation of integrin αvβ6a and transforming growth factor beta signalling in a three-dimensional in vitro wound healing model. Int J Oral Maxillofac Surg. 2014;43(3):373-80. doi: 10.1016/j.ijom.2013.06.016.
Bocanegra-Perez S, Vicente-Barrero M, Knezevic M, Castellano-Navarro JM, Rodríguez-Bocanegra E, Rodríguez-Millares J, et al. Use of platelet-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw. Int J Oral Maxillofac Surg. 2012;41(4):1410-5. doi: 10.1016/j.ijom.2012.04.020.
Freiberger JJ. Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2009;67:96-106. doi: 10.1016/j.joms.2008.12.003.
Rahim I, Salt S, Heliotis M. Successful long-term mandibular reconstruction and rehabilitation using non-vascularised autologous bone graft and recombinant human BMP-7 with subsequent endosseous implant in a patient with bisphosphonate-related osteonecrosis of the jaw. Br J Oral Maxillofac Surg. 2015;53(9):870-4. doi: 10.1016/j.bjoms.2015.08.006.
Lee JY, Kim IR, Park BS, Kim YD, Chung IK, Song JM, et al. Effect of low-level laser therapy on oral keratinocytes exposed to bisphosphonate. Lasers Med Sci. 2015;30(2):635-43. doi: 10.1007/s10103-013-1382-6.
Vescovi P, Meleti M, Merigo E, Manfredi M, Fornaini C, Guidotti R, et al. Case series of 589 tooth extractions in patients under bisphosphonates therapy. Proposal of a clinical protocol supported by Nd:YAG low-level laser therapy. Med Oral Patol Oral Cir Bucal. 2013;18(4):680-5. doi:10.4317/medoral.18812.
Scoletta M, Arduino PG, Reggio L, Dalmasso P, Mozzati M. Effect of low-level laser irradiation on bisphosphonate-induced osteonecrosis of the jaws: preliminary results of a prospective study. Photomed Laser Surg. 2010;28(2):179-84. doi: 10.1089/pho.2009.2501.
de Freitas LF, Hamblin MR. Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy. IEEE J Sel Top Quantum Electron. 2016;22(3):7000417. doi: 10.1109/JSTQE.2016.2561201.
Statkievicz C, Toro LF, de Mello-Neto JM, de Sá DP, Casatti CA, Issa JPM, et al. Photomodulation multiple sessions as a promising preventive therapy for medication-related osteonecrosis of the jaws after tooth extraction in rats. J Photochem Photobiol B. 2018;184:7-17. doi: 10.1016/j.jphotobiol.2018.05.004.
Noda M, Aoki A, Mizutani K, Lin T, Komaki M, Shibata S, et al. High-frequency pulsed low-level diode laser therapy accelerates wound healing of tooth extraction socket: An in vivo study. Lasers Surg Med. 2016;48(10):955-64. doi: 10.1002/lsm.22560.
Park JB, Ahn SJ, Kang YG, Kim EC, Heo JS, Kang KL. Effects of increased low-level diode laser irradiation time on extraction socket healing in rats. Lasers Med Sci. 2015;30(2):719-26. doi: 10.1007/s10103-013-1402-6.
Korany NS, Mehanni SS, Hakam HM, El-Maghraby EM. Evaluation of socket healing in irradiated rats after diode laser exposure (histological and morphometric studies). Arch Oral Biol. 2012;57(7):884-91. doi: 10.1016/j.archoralbio.2012.01.009.
Eroglu CN, Keskin Tunc S. Effectiveness of Single Session of Low-Level Laser Therapy with a 940 nm Wavelength Diode Laser on Pain, Swelling, and Trismus After Impacted Third Molar Surgery. Photomed Laser Surg. 2016;34(9):406-10. doi: 10.1089/pho.2016.4101.
Ferrante M, Petrini M, Trentini P, Perfetti G, Spoto G. Effect of low-level laser therapy after extraction of impacted lower third molars. Lasers Med Sci. 2013;28(3):845-9. doi: 10.1007/s10103-012-1174-4.
Batinjan G, Filipović Zore I, Rupić I, Bago Jurič I, Zore Z, Gabrić Pandurić D. Assessing Health-Related Quality of Life with Antimicrobial Photodynamic Therapy (APDT) and Low Level Laser Therapy (LLLT) after Third Molar Removal. J Lasers Med Sci. 2013;4(3):120-6.
Vescovi P, Giovannacci I, Merigo E, Meleti M, Manfredi M, Fornaini C, et al. Tooth extractions in high-risk patients under bisphosphonate therapy and previously affected with osteonecrosis of the jaws: surgical protocol supported by low-level laser therapy. J Craniofac Surg. 2015;26(3):696-9. doi: 10.1097/SCS.0000000000001665.
Latifyan S, Genot MT, Klastersky J. Bisphosphonate-related osteonecrosis of the jaw: a review of the potential efficacy of low-level laser therapy. Support Care Cancer. 2016;24(9):3687-93. doi: 10.1007/s00520-016-3139-9.
Weber JB, Camilotti RS, Ponte ME. Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): a systematic review. Lasers Med Sci. 2016;31(6):1261-72. doi: 10.1007/s10103-016-1929-4.
Ruggiero SL, Woo SB. Biophosphonate-related osteonecrosis of the jaws. Dent Clin North Am. 2008;52(1):111-28. doi:10.1016/j.cden.2007.09.002.
Otto S, Schreyer C, Hafner S, Mast G, Ehrenfeld M, Stürzenbaum S, et al. Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment. J Craniomaxillofac Surg. 2012;40(4):303-9. doi: 10.1016/j.jcms.2011.05.003.
Saad F, Brown JE, Van Poznak C, Ibrahim T, Stemmer SM, Stopeck AT, et al. Incidence, risk factors, and outcomes of osteonecrosis of the jaws: integrated analysis from tree blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol. 2012;23(5):1341-7. doi: 10.1093/annonc/mdr435.
Berrone M, Florindi FU, Carbone V, Aldiano C, Pentenero M. Stage 3 Medication-Related Osteonecrosis of the Posterior Maxilla: Surgical Treatment Using a Pedicled Buccal Fat Pad Flap: Case Reports. J Oral Maxillofac Surg. 2015;73(11):2082-6. doi: 10.1016/j.joms.2015.06.165.
Ristow O, Pautke C. Auto-fluorescence of the bone and its use for delineation of bone necrosis. Int J Oral Maxillofac Surg. 2014;43(11):1391-3. doi: 10.1016/j.ijom.2014.07.017.
Hoefert S, Eufinger H. Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg. 2011;69(2):362-80. doi: 10.1016/j.joms.2010.06.200.
Altay MA, Tasar F, Tosun E, Kan B. Low-level laser therapy supported surgical treatment of bisphosphonate related osteonecrosis of jaws: a retrospective analysis of 11 cases. Photomed Laser Surg. 2014;32(8):468-75. doi: 10.1089/pho.2014.3742.
Oliveira FA, Matos AA, Santesso MR, Tokuhara CK, Leite AL, Bagnato VS, et al. Low intensity lasers differently induce primary human osteoblast proliferation and differentiation. J Photochem Photobiol B. 2016;163:14-21. doi: 10.1016/j.jphotobiol.2016.08.006.
Spanemberg JC, Figueiredo MA, Cherubini K, Salum FG. Low-level Laser Therapy: A Review of Its Applications in the Management of Oral Mucosal Disorder. Altern Ther Health Med. 2016;22(6):24-31.
de Medeiros ML, Araújo-Filho I, da Silva EM, de Sousa Queiroz WS, Soares CD, de Carvalho MG, et al. Effect of low-level laser therapy on angiogenesis and matrix metalloproteinase-2 immunoexpression in wound repair. Lasers Med Sci. 2017;32:(1):35-43. doi: 10.1007/s10103-016-2080-y.
Enwemeka CS, Parker JC, Dowdy DS, Harkness EE, Sanford LE, Woodruff LD. The efficacy of low-power lasers in tissue repair and pain control: a meta-analysis study. Photomed Laser Surg. 2004;22(4):323-9. doi: 10.1089/pho.2004.22.323.
Romeo U, Galanakis A, Marias C, Vecchio AD, Tenore G, Palaia G, et al. Observation of pain control in patients with bisphosphonate-induced osteonecrosis using low level laser therapy: preliminary results. Photomed Laser Surg. 2011;29(7):447-52. doi: 10.1089/pho.2010.2835.
Vescovi P, Merigo E, Meleti M, Manfredi M, Fornaini C, Nammour S, et al. Conservative Surgical Management of Stage I Bisphosphonate-Related Osteonecrosis of the Jaw. Int J Dent. 2014. doi: 10.1155/2014/107690.
Martins MA, Martins MD, Lascala CA, Curi MM, Migliorati CA, Tenis CA, et al. Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study. Oral Oncol. 2012;48(1):79-84. doi: 10.1016/j.oraloncology.2011.08.010.
- Abstract Viewed: 622 times
- PDF Downloaded: 383 times